News

Filter

Current filters:

None

Popular Filters

1 to 25 of 8863 results

Orphan status in Europe for Alexion’s Soliris in myasthenia gravis

01-08-2014

The European Commission has granted orphan drug designation (ODD) to US drugmaker Alexion Pharmaceuticals’…

Alexion PharmaceuticalsBiotechnologyEuropeRare diseasesRegulationSoliris

Ziopharm and Solasia amend collaboration for darinaparsin

01-08-2014

US drug developer Ziopharm Oncology and Japan’s Solasia Pharma, a developer of oncology pharmaceuticals…

darinaparsinGlobalLicensingOncologyPharmaceuticalSolasia PharmaZinaparZiopharm Oncology

French regulators push for huge cut in hypnotic benzodiazepine reimbursement

French regulators push for huge cut in hypnotic benzodiazepine reimbursement

01-08-2014

French regulators are attempting to discourage the over-consumption and misuse of hypnotic benzodiazepines…

diazepamFranceFrench governmentNeurologicalPharmaceuticalRegulation

This week’s pharma financial results in brief

This week’s pharma financial results in brief

01-08-2014

A whole host of pharma, biotech and generics companies released second quarter and first half results…

FinancialGlobal

UK aims to become world number one in DNA testing with new investment

UK aims to become world number one in DNA testing with new investment

01-08-2014

David Cameron, the UK Prime Minister, has announced a package of investment worth more than £300 million…

BiotechnologyDavid CameronGeneticsIlluminaMedical Research CouncilResearchUK

USA’s 340B Drug Discount Program “needs more oversight,” says BIO

USA’s 340B Drug Discount Program “needs more oversight,” says BIO

01-08-2014

The US Biotechnology Industry Organization’s (BIO) Laurel Todd shared concerns that the 340B program…

BiotechnologyFinancialHealthcareRegulationUSA

Kyowa Hakko Kirin files for KW-3357 approval in Japan

Kyowa Hakko Kirin files for KW-3357 approval in Japan

01-08-2014

Japanese drugmaker Kyowa Hakko Kirin has filed an application for marketing approval with the Ministry…

HematologyJapanKW-3357Kyowa Hakko KirinPharmaceuticalRare diseasesRegulationThrombus

UCB expands access to clinical trial data

UCB expands access to clinical trial data

01-08-2014

Belgian drugmaker UCB is now part of the Multi-Sponsor Environment, allowing for the responsible sharing…

BelgiumClinical researchPharmaceuticalResearchUCB

FDA approves Boehringer’s Striverdi Respimat for COPD

FDA approves Boehringer’s Striverdi Respimat for COPD

01-08-2014

The US Food and Drug Administration has approved German family-owned pharma major Boehringer Ingelheim’s…

Boehringer IngelheimPharmaceuticalPulmonologyRegulationRespiratory and PulmonaryStriverdi RespimatUSA

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

Teva’s 2nd-qtr sales and earnings miss analysts' estimates

31-07-2014

Israel’s Teva Pharmaceutical Industries, the world’s biggest generics drugmaker, reported disappointing…

CopaxoneFinancialGenericsIsraelTeva Pharmaceutical Industries

UCB reports solid 1st-half performance

UCB reports solid 1st-half performance

31-07-2014

Belgian drugmaker UCB posted first-half 2014 revenue of 1.76 billion euros ($2.36 billion), plus 6%,…

BelgiumChemistryChief executiveEURFinancialOrganic chemistryPharmaceuticalUCBVimpat

US seniors save more than $11.5 billion on Rx drugs since 2010

US seniors save more than $11.5 billion on Rx drugs since 2010

31-07-2014

Information released by the US Department of Health and Human Services shows that more than 8.2 million…

FinancialHealthcareMedicarePharmaceuticalUSA

Harlan aims to provide expertise for biologics and biosimilars

31-07-2014

Switzerland-based Harlan Laboratories, a privately held provider of general and specialty toxicology…

BiosimilarsBiotechnologyContract research servicesHarlanRegulationResearchSwitzerlandToxicology services

Janssen’s simeprevir for hepatitis C shows good efficacy in Phase II trial

Janssen’s simeprevir for hepatitis C shows good efficacy in Phase II trial

31-07-2014

Some 92% of genotype 1 chronic hepatitis C virus (HCV) adult patients treated with US health care giant…

Anti-viralsGilead SciencesIrelandJanssenPharmaceuticalResearchsimeprevirsofosbuvir

Valeant's revenue jumps 86% to hit $2 billion

Valeant's revenue jumps 86% to hit $2 billion

31-07-2014

Canadian pharma company Valeant, which is currently attempting a takeover of Allergan, reported a 12-fold…

AllerganBausch & LombCanadaFinancialPharmaceuticalValeantValeant Pharmaceuticals

Albumin sales to play major part in growth of billion-dollar critical care market

Albumin sales to play major part in growth of billion-dollar critical care market

31-07-2014

The critical care market across eight major countries will grow to $2.5 billion by 2020, according to…

AlbuminBlood proteinsGlobalMarkets & MarketingPharmaceutical

AstraZeneca 2nd-qtr earnings leap, beating expectations

AstraZeneca 2nd-qtr earnings leap, beating expectations

31-07-2014

Anglo-Swedish pharma major AstraZeneca, which earlier this year defended itself against an unsolicited…

AstraZenecaBusiness FinanceFinancialPharmaceuticalUK

Meda in $3.1 billion deal to acquire Italy’s Rottapharm

Meda in $3.1 billion deal to acquire Italy’s Rottapharm

31-07-2014

Sweden’s Meda says it has entered into a definitive agreement to acquire Rottapharm Madaus, an Italian…

Business FinanceItalyMedaMergers & AcquisitionsMergers and acquisitionsPharmaceuticalRottapharm MadausSwedenSweden

1 to 25 of 8863 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top